General Cannabis Competitors

Innovative Industrial Properties (NYSE:IIPR) and General Cannabis (OTCMKTS:CANN) are both finance companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings.

Analyst Recommendations

This is a breakdown of current ratings for Innovative Industrial Properties and General Cannabis, as reported by MarketBeat.

Innovative Industrial Properties presently has a consensus target price of $192.4286, indicating a potential upside of 1.82%. Given Innovative Industrial Properties' higher probable upside, equities analysts plainly believe Innovative Industrial Properties is more favorable than General Cannabis.

Profitability

This table compares Innovative Industrial Properties and General Cannabis' net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Innovative Industrial Properties and General Cannabis' revenue, earnings per share and valuation.

Innovative Industrial Properties has higher revenue and earnings than General Cannabis.

Institutional & Insider Ownership

74.9% of Innovative Industrial Properties shares are owned by institutional investors. 2.9% of Innovative Industrial Properties shares are owned by company insiders. Comparatively, 38.0% of General Cannabis shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Risk and Volatility

Innovative Industrial Properties has a beta of 1.52, suggesting that its stock price is 52% more volatile than the S&P 500. Comparatively, General Cannabis has a beta of 0.95, suggesting that its stock price is 5% less volatile than the S&P 500.

Summary

Innovative Industrial Properties beats General Cannabis on 10 of the 11 factors compared between the two stocks.

General Cannabis (OTCMKTS:CANN) and GrowGeneration (NASDAQ:GRWG) are both business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

Earnings and Valuation

This table compares General Cannabis and GrowGeneration's gross revenue, earnings per share (EPS) and valuation.

GrowGeneration has higher revenue and earnings than General Cannabis.

Insider and Institutional Ownership

51.3% of GrowGeneration shares are held by institutional investors. 38.0% of General Cannabis shares are held by company insiders. Comparatively, 13.6% of GrowGeneration shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of current recommendations for General Cannabis and GrowGeneration, as reported by MarketBeat.

GrowGeneration has a consensus target price of $49.5714, suggesting a potential downside of 8.24%. Given GrowGeneration's higher possible upside, analysts plainly believe GrowGeneration is more favorable than General Cannabis.

Profitability

This table compares General Cannabis and GrowGeneration's net margins, return on equity and return on assets.

Risk & Volatility

General Cannabis has a beta of 0.95, indicating that its share price is 5% less volatile than the S&P 500. Comparatively, GrowGeneration has a beta of 3.09, indicating that its share price is 209% more volatile than the S&P 500.

Summary

GrowGeneration beats General Cannabis on 10 of the 11 factors compared between the two stocks.

22nd Century Group (NYSEAMERICAN:XXII) and General Cannabis (OTCMKTS:CANN) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, institutional ownership and analyst recommendations.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for 22nd Century Group and General Cannabis, as provided by MarketBeat.com.

Earnings & Valuation

This table compares 22nd Century Group and General Cannabis' gross revenue, earnings per share (EPS) and valuation.

22nd Century Group has higher earnings, but lower revenue than General Cannabis.

Profitability

This table compares 22nd Century Group and General Cannabis' net margins, return on equity and return on assets.

Summary

22nd Century Group beats General Cannabis on 3 of the 4 factors compared between the two stocks.

General Cannabis (OTCMKTS:CANN) and KushCo (OTCMKTS:KSHB) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.

Risk and Volatility

General Cannabis has a beta of 0.95, meaning that its stock price is 5% less volatile than the S&P 500. Comparatively, KushCo has a beta of 1.91, meaning that its stock price is 91% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for General Cannabis and KushCo, as provided by MarketBeat.com.

KushCo has a consensus price target of $1.8750, suggesting a potential upside of 45.35%. Given KushCo's higher probable upside, analysts clearly believe KushCo is more favorable than General Cannabis.

Insider and Institutional Ownership

0.0% of KushCo shares are owned by institutional investors. 38.0% of General Cannabis shares are owned by company insiders. Comparatively, 17.3% of KushCo shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares General Cannabis and KushCo's top-line revenue, earnings per share (EPS) and valuation.

General Cannabis has higher earnings, but lower revenue than KushCo.

Profitability

This table compares General Cannabis and KushCo's net margins, return on equity and return on assets.

Summary

KushCo beats General Cannabis on 7 of the 11 factors compared between the two stocks.

NSAV (OTCMKTS:NSAV) and General Cannabis (OTCMKTS:CANN) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings and risk.

Analyst Recommendations

This is a summary of recent ratings and price targets for NSAV and General Cannabis, as reported by MarketBeat.

Earnings & Valuation

This table compares NSAV and General Cannabis' revenue, earnings per share (EPS) and valuation.

NSAV has higher earnings, but lower revenue than General Cannabis.

Volatility & Risk

NSAV has a beta of 3.85, indicating that its stock price is 285% more volatile than the S&P 500. Comparatively, General Cannabis has a beta of 0.95, indicating that its stock price is 5% less volatile than the S&P 500.

Profitability

This table compares NSAV and General Cannabis' net margins, return on equity and return on assets.

Summary

NSAV beats General Cannabis on 3 of the 4 factors compared between the two stocks.

Terra Tech (OTCMKTS:TRTC) and General Cannabis (OTCMKTS:CANN) are both small-cap industrial products companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, profitability, risk and earnings.

Risk and Volatility

Terra Tech has a beta of 2.4, indicating that its share price is 140% more volatile than the S&P 500. Comparatively, General Cannabis has a beta of 0.95, indicating that its share price is 5% less volatile than the S&P 500.

Earnings & Valuation

This table compares Terra Tech and General Cannabis' top-line revenue, earnings per share and valuation.

General Cannabis has lower revenue, but higher earnings than Terra Tech.

Analyst Ratings

This is a summary of recent ratings and target prices for Terra Tech and General Cannabis, as reported by MarketBeat.

Insider & Institutional Ownership

0.1% of Terra Tech shares are owned by institutional investors. 6.7% of Terra Tech shares are owned by insiders. Comparatively, 38.0% of General Cannabis shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Terra Tech and General Cannabis' net margins, return on equity and return on assets.

Summary

General Cannabis beats Terra Tech on 5 of the 9 factors compared between the two stocks.